|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/145 | |
| A61P 17/10 | |||
| A61K 8/46 | |||
| A61Q 19/00 | |||
| A61K 9/00 | |||
| A61K 9/06 | |||
| A61K 47/32 |
| (11) | Number of the document | 2249765 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08726129.3 |
| Date of filing the European patent application | 2008-02-27 | |
| (97) | Date of publication of the European application | 2010-11-17 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/002549 |
| Date | 2008-02-27 |
| (87) | Number | WO 2009/108147 |
| Date | 2009-09-03 |
| (72) |
GARRETT, John Steven, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | Dapsone to treat rosacea |
| Dapsone to treat rosacea |